Stock Analysis·← Pickers

YCBD

cbdMD, Inc.

cbdMD, Inc. (YCBD) is currently in a downtrend, trading below both the 50-day and 200-day moving averages. RSI is at 39.5, with 0/3 trend checks passing.

Price
$0.64
2026-07-16
Trend score
0/3
Downtrend
RSI (14)
39.5
Neutral
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

YCBD with MA50 and MA200

2.271.821.370.920.4707/3110/2401/2204/1707/15
YCBD2025-07-312026-07-15
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$0.74-13.85% vs price
MA200
$0.87-26.73% vs price
RSI (14)
39.5Neutral zone
MACD Signal
MixedMACD near signal line
Macro Support
Not identifiedNo repeated weekly support zone found
Support Quality
Volume data unavailable
Chart Summary
Trend summary for YCBD

cbdMD, Inc. (YCBD) currently looks weaker on the chart and is not showing much trend strength. The latest available price is $0.64, and 0 of 3 core trend checks are currently passing. Price is trading below the 50-day moving average by 13.8% and below the 200-day moving average by 26.7%.

Momentum and stretch context

YCBD currently has an RSI reading of 39.5, which leans a little softer than neutral. That does not automatically make the chart bearish, but it does suggest momentum is not especially strong right now.

What traders may watch next

For traders reviewing YCBD next, the main question is whether weakness is starting to stabilise or whether the chart still looks vulnerable to further downside. Some traders may watch for bounce attempts, but others will want to see stronger proof that the trend is improving before treating the stock as a cleaner setup.

Company profile

About cbdMD, Inc.

cbdMD, Inc. is engaged in the production and distribution of a diverse array of cannabidiol (CBD) products. The company oversees and markets several consumer-oriented, hemp-derived CBD brands, notably its primary brand cbdMD, alongside Paw CBD and cbdMD Botanicals. Under the cbdMD label, its offerings span various items, including CBD tinctures, edible gummies, topical applications, capsules, bath bombs, bath salts, and solutions designed to aid sleep. Furthermore, its Paw CBD brand caters to pets with veterinarian-formulated products such as tinctures, edible chews, and topical treatments. The company's merchandise reaches customers throughout the United States via its proprietary e-commerce platform, various third-party online retail sites, wholesale partners, and physical brick-and-mortar establishments. cbdMD, Inc. also maintains a research collaboration with the University of Mississippi, focusing on the discovery of novel cannabinoids. Incorporated in 2015, the firm was previously known as Level Brands, Inc. before officially changing its name to cbdMD, Inc. in May 2019, and its corporate headquarters are situated in Charlotte, North Carolina.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
T. Ronan Kennedy
Employees
42
Market cap
$6.7M
Beta
2.13
52-week range
$0.47 – $2.56
Dividend
No
Exchange
AMEX
Country
US
IPO date
17 Nov 2017
ISIN
US12482W4087
CUSIP
12482W408
Website
cbdmd.com
Company profile data from Financial Modeling Prep. YCBD listed on AMEX.
Share dilution

YCBD shares outstanding over time

Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.

Jun 2019Mar 2026
Shares outstanding (latest)
10.4M
Since Jun 2019
+1591.0%
Trend
More shares outstanding
Historical shares-outstanding data from Financial Modeling Prep. YCBD28 data points from Jun 2019 to Mar 2026.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about YCBD

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.